Yimutian flagged by Nasdaq over $1 bid price rule
Yimutian Inc. reported that Nasdaq has notified the company it is not meeting the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market.
Rhea-AI Filing Summary
Yimutian Inc. reported that Nasdaq has notified the company it is not meeting the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market. The deficiency is based on closing bid prices between February 18, 2026 and April 1, 2026.
The notice has no immediate effect on the listing status, and the company’s ADSs will continue trading on Nasdaq. Yimutian has 180 calendar days, until September 29, 2026, to regain compliance by having its ADS closing bid price at or above $1.00 for at least ten consecutive business days.
The company is evaluating options to regain compliance, including a potential change to the ratio between its ADSs and Class A ordinary shares, but there is no assurance it will meet Nasdaq’s continued listing requirements or avoid possible delisting.
Positive
- None.
Negative
- Nasdaq minimum bid price deficiency: Yimutian’s ADSs failed to meet the $1.00 minimum bid price requirement over an extended period and now face a September 29, 2026 deadline to regain compliance or risk potential delisting from the Nasdaq Global Market.
Insights
Yimutian faces Nasdaq bid-price noncompliance with a defined cure window.
Yimutian Inc. has fallen below Nasdaq’s $1.00 minimum bid price requirement, triggering a formal deficiency notice. The company’s ADSs remain on the Nasdaq Global Market, but it now operates under Listing Rule 5810(c)(3)(A)’s remediation framework.
The company has until September 29, 2026 to restore its ADS closing bid to at least $1.00 for ten consecutive business days. Management is considering structural steps, including changing the ratio between ADSs and Class A ordinary shares, which can effectively adjust the per-ADS price without altering overall equity value.
If Yimutian fails to regain compliance or qualify for an additional cure period, its securities may be subject to delisting from Nasdaq. That would shift trading to less prominent venues and could affect liquidity, so subsequent disclosures on any ratio change or other corrective actions will be important context from future company filings.
Key Figures
Key Terms
minimum bid price requirement financial
Nasdaq Listing Rules regulatory
Listing Rule 5450(a)(1) regulatory
Listing Rule 5810(c)(3)(A) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq issue did Yimutian Inc. (YMT) disclose on its Form 6-K?
Does the Nasdaq minimum bid price notice immediately affect Yimutian Inc. (YMT) listing?
How long does Yimutian Inc. (YMT) have to regain Nasdaq bid price compliance?
What steps may Yimutian Inc. (YMT) take to address the Nasdaq deficiency?
Could Yimutian Inc. (YMT) be delisted from Nasdaq due to the bid price issue?
Does the Nasdaq notice change Yimutian Inc. (YMT) business or SEC reporting obligations?
AI-generated analysis. How Rhea-AI works. Not financial advice.